RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.

A cost-effectiveness evaluation of adding rosiglitazone versus sulphonylurea to metformin in a US obese Type 2 diabetes population

Beale, SJ., Bagust, A., Richter, A., Thieda, P., & Perry, A. (2003). A cost-effectiveness evaluation of adding rosiglitazone versus sulphonylurea to metformin in a US obese Type 2 diabetes population. Diabetologia, 46, A444-A444.

Publications Info

To contact an RTI author, request a report, or for additional information about publications by our experts, send us your request.

Meet the Experts

Navigate to Barbara L. Kroner

Barbara L. Kroner

Navigate to Barri Burrus

Barri Burrus

Navigate to Cynthia Salmons

Cynthia Salmons

Navigate to Dan Pratt

Dan Pratt

Navigate to Donna Womack

Donna Womack

Navigate to Gary A. Zarkin

Gary A. Zarkin

Navigate to Gayle Bieler

Gayle Bieler

Navigate to J. Todd Ennis

J. Todd Ennis